GI bits and pieces! Flashcards
COELIAC DISEASE
- Only effective option = AVOID GLUTEN
- Occurs in the small intestine
- Associated with GLUTEN: wheat, barley and rye => causes an immune response in intestinal mucosa
- Can cause malabsorption of nutrients
Aims:
- Manage symptoms => diarrhoea, bloating and abdo pain
- Avoid malnutrition => give Vit D, Ca, and other nutrients under supervision
DIVERTICULAR DISEASE AND DIVERTICULITIS
Treatment PRN:
- fibre
- bulk-forming laxatives - treats constipation
- paracetamol - pain
DIVERTICULOSIS
Small pouches but asymptomatic
DIVERTICULAR DISEASE
Small pouches but SYMPTOMATIC
- abdo pain
- constipation
- diarrhoea
- rectal bleeding
ACUTE DIVERTICULITIS
Pouches become inflamed or infected
- severe abdo pain
- fever
- significant rectal bleeding
COMPLICATED ACUTE DIVERTICULITIS
- abscess
- perforation
- fistula
- obstruction
- sepsis
- haemorrhage
CROHN’S DISEASE
This affects the whole GI tract - associated with thickened wall, extending through all layers, with deep ulceration and SKIPPED LESIONS!
Complications include:
- intestinal strictures or fistulae
- anaemia and malnutrition
- colorectal and delayed puberty in kids
- growth failure and delayed puberty in kids
- extra-intestinal manifestation => arthritis or joints, eyes, liver and skin abnormalities
Crohn’s disease - ACUTE treatment
1st flare-up in 12-MONTH PERIOD:
1. Monotherapy w/ either PREDNISOLONE, METHYLPREDNISOLONE or IV HYDROCORTISONE
2. If pt has distal ileal, ileocaecal or right sided disease:
- BUDESONIDE if normal treatment doesn’t work
3. Aminosalicylates (SULFASALAZINE or MESALAZINE) - less SEs, but less effective
2+ flare-ups in 12-MONTH PERIOD:
1. Add AZATHIOPRINE or MERCAPTOPURINE
2. METHOTREXATE may be added if 1st line is CI
3. Severe = monoclonal antibodies
Crohn’s disease - MD treatment
- Encourage smoking cessation
- Monotherapy of either AZATHIOPRINE or MERCAPTOPURINE
- METHOTREXATE can be used if used in induction or can’t tolerate A/M
Post-surgery:
- AZATHIOPRINE + METRONIDAZOLE
- AZATHIOPRINE alone if metronidazole isn’t tolerated
Diarrhoea associated, thus, can use:
To manage diarrhoea in those who don’t have colitis
- LOPERAMIDE
- CODEINE
- COLESTYRAMINE - relief of diarrhoea associated with CD
Fistulating Crohn’s Disease
This is when a fistula develops between the intestine and perianal skin, bladder, and vagina.
Can be left ALONE if asymptomatic
To improve symptoms (not fully heal):
- METRONIDAZOLE +/- CIPROFLOXACIN
- Metronidazole is given for 1 month - no longer than 3 months due to peripheral neuropathy
MD
1. AZATHIOPRINE or MERCAPTOPURINE
2. Infliximab if not responding
- treatment lasts AT LEAST 1 YEAR
UC
- Most common in 15 - 25 years!
Affects region from the rectum to the whole colon - associated with bloody diarrhoea, defecation urgency or abdominal pain.
Complications include:
- colorectal cancer
- secondary osteoporosis
- VTE
- toxic megacolon
UC - types
UC is a continuous pattern.
CD is patchy and has skipped lesions.
- Proctitis
- Proctosigmoiditis
- Distal/ Left-sided
- Extensive colitis
- Pancolitis
UC - Acute (mild - moderate)
DISTAL
- Rectal prep = suppositories or enemas
- foam preps if pt has difficulty retaining liquid enema
EXTENDED
- systemic meds
DIARRHOEA
- AVOID loperamide OR codeine as it can cause toxic megacolon. This is only initiated under specialist advice
UC - Acute (mild - moderate) - PROCTITIS (suppositories)
- Topical aminosalicylate
- Add oral aminosalicylates if no improvement after 4 wks
- Still no improvement => TOPICAL or PO corticosteroid for 4-8 wks
- Pts can use PO aminosalicylates 1st line if preferred although not as effective
- If aminosalicylates CI => TOPICAL or PO corticosteroids for 4-8 wks
UC - Acute (mild - moderate) - PROCTOSIGMOIDITIS (foam preps - foam preps and suppositories are easier to retain than liquid enemas) & LEFT-SIDED UC (enemas)
- Topical aminosalicylates
2a. Add high-dose PO aminosalicylate if no improvement after 4 wks OR
2b. high-dose PO aminosalicylate + 4-8 wks of TOPICAL corticosteroids
- Stop treatment and offer PO aminosalicylate + 4-8 wk of PO corticosteroids
- Pts can use high-dose PO aminosalicylates first if preferred although less effective. If aminosalicylates are CI => topical or PO corticosteroids fro 4-8 wks
UC - Acute (mild - moderate) - EXTENSIVE UC (PO)
- Topical aminosalicylate + high-dose PO aminosalicylate
- No change after 4 wks => stop topical aminosalicylate and offer high-dose PO aminosalicylate + PO corticosteroid for 4-8 wks
- If aminosalicylate CI => PO corticosteroid for 4-8 wks
UC - Acute (SEVERE)
MEDICAL EMERGENCY
- life-threatening
- IV HYDROCORTISONE or METHYLPREDNISOLONE and assess need for surgery
- If IV steroids CI => use IV CICLOSPORIN or surgery
- If symptoms haven’t helped within 72h
1. IV STEROID + IV CICLOSPORIN
2. Surgery - INFLIXIMABif ciclosporin is CI
UC - MD
- PO AMINOSALICYLATES
- corticosteroids not okay due to SEs
- more effective as OD, but may cause more SEs
Proctitis or Proctosigmoiditis:
1. RECTAL +/- PO AMINOSALICYLATES
- PO can be given alone if rectal isn’t required
LEFT-SIDED or EXTENSIVE:
1. Low dose PO AMINOSALICYLATE
2+ flares in 12 months:
1. PO AZATHIOPRINE or MERCAPTOPURINE
- Give monoclonal antibodies if no effect
UC - MD after a single ep of acute-severe UC
1st: PO azathioprine or mercaptopurine
2nd: CI in 1st line => PO aminosalicylates
Disease refractory to immunomodulatory therapy despite dose optimisation or where conventional treatment is not tolerated or CI:
1st: Infliximab, adalimumab or golimumab - choice made on an individual basis
2nd: Vedolizumab
3rd: Tofacitinib
Aminosalicylates
Sulfasalazine (5-ASA and sulfapyridine), Balsalazide, Mesalazine (5-ASA), Olsalazine
- Nephrotoxic = monitor b4 initiation, at 3 months, then annually
- Hepatotoxic = monitor at monthly intervals for first 3 months
- Blood disorders = monitor at monthly intervals for first 3 months. Perform FBC and stop drug STAT if signs of blood dyscrasia
- CI: salicylate hypersensitivity - e.g. itching and hives
- Stains contact lenses orange-yellow
SE: (common) leucopenia, GI se’s, pruritis, headache
Monitoring: FBC, CrCl/eGFR, LFTs. Haematological abnormalities occur in the first 3 - 6 months of treatment - discont. if these occur.
Interactions:
- Lactulose + mesalazine = lactulose lowers pH in the intestines, preventing the sufficient release of the active ingredient in EC or MR preps.
IBS - condition and risk factors
Common, chronic, relapsive and often life-long - associated with abdominal pain, diarrhoea or constipation, urgency, incomplete defaecation and passing mucous
More common in women and ages 20 - 30 years
Exacerbated by:
- coffee, alcohol, milk
- large meals
- fried foods
- stress
IBS - non-drug treatment
- increase exercise
- eat regular meals
- reduce fresh fruit consumption to 3 portions/day
- reduce insoluble fibre
- drink at least 8 cups of water/day
- reduce caffeine, alcohol and fizzy drinks
- avoid SORBITOL (sugar alcohol) if you’ve diarrhoea
- reduce stress
IBS - drug treatment
OTC:
- Antispasmodics (direct relaxants of intestinal smooth muscle): ALVERINE (dizziness; driving warning), MEBEVERINE- (alverine and mebeverine are CI in paralytic ileus); and peppermint oil (heartburn; local irritation of mouth/oesophagus - SWALLOW CAPS WHOLE!)
- Laxatives: if constipated (not LACTULOSE as it can cause bloating)
- LOPERAMIDE: if experiencing diarrhoea
- Antimuscarinics: Hyoscine BUTylbromide (avoid in cardiac disease)
2nd line treatment for pain if OTC fails:
1. Low dose TCA: AMITRIPTYLINE
2. SSRI if TCA fails
Use is UNLICENSED
ANTIMUSCARINICS - sympathetic pathway
SE: blurred vision, urinary retention, constipation, dry mouth
- tachycardia, palpitations and arrhythmias (increases heart rate)
- pupil dilation
- reduced bronchial secretions
- angle-closure glaucoma = raises intraocular pressure
- confusion in elderly
- drowsiness; impairs driving
Caution:
- susceptibility to angle-closure glaucoma
- conditions causing tachycardia => e.g. hyperthyroidism
- CVS => e.g. arrhythmias, congestive HF
CI:
- prostatic enlargement, urinary retention
- paralytic ileus, GI obstruction, toxic megacolon
- myasthenia gravis (characterised by muscle weakness)
- narrow-angle (closed-angle) glaucoma
Hyoscine butylbromide injection:
MHRA = risk of serious AE in pts with underlying cardiac disease = tachycardia, hypotension, anaphylaxis (likely fatal in coronary heart disease)
- CI in tachycardia. Caution in cardiac disease. Monitor pts and have resuscitation equipment readily available.